AIM1 and LINE-1 epigenetic aberrations in tumor and serum relate to melanoma progression and disease outcome - Wikidata - wikimedia - TriplyDB

AIM1 and LINE-1 epigenetic aberrations in tumor and serum relate to melanoma progression and disease outcome

AIM1 and LINE-1 epigenetic aberrations in tumor and serum relate to melanoma progression and disease outcome

http://www.wikidata.org/entity/Q35962455

about

Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease Methylated circulating tumor DNA in blood: power in cancer prognosis and response The Fine LINE: Methylation Drawing the Cancer Landscape Progression of cutaneous melanoma: implications for treatment Emerging technologies for studying DNA methylation for the molecular diagnosis of cancer Retrotransposon hypomethylation in melanoma and expression of a placenta-specific gene Genes Downregulated in Endometriosis Are Located Near the Known Imprinting Genes.DNA methylation profiles in primary cutaneous melanomas are associated with clinically significant pathologic features.Melanoma genotypes and phenotypes get personal.The prognostic value of global DNA hypomethylation in cancer: a meta-analysis Using RNA sequencing for identifying gene imprinting and random monoallelic expression in human placenta.Altered DNA methylation profile in idiopathic pulmonary fibrosis.RASSF8 regulates progression of cutaneous melanoma through nuclear factor-κb.Transposable hypomethylation is associated with metastatic capacity of primary melanomas.Metastatic risk and resistance to BRAF inhibitors in melanoma defined by selective allelic loss of ATG5.Epigenome-wide DNA methylation landscape of melanoma progression to brain metastasis reveals aberrations on homeobox D cluster associated with prognosis.Liquid Biopsies for Assessing Metastatic Melanoma Progression.LINE-1 hypomethylation status of circulating cell-free DNA in plasma as a biomarker for colorectal cancer.Diagnostic and prognostic value of circulating tumor-related DNA in cancer patients.Clinical implications of the LINE-1 methylation levels in patients with gastrointestinal cancer.LINE-1 in cancer: multifaceted functions and potential clinical implications.Circulating epigenetic biomarkers in melanoma.Liquid biopsy utility for the surveillance of cutaneous malignant melanoma patients Tumor necrosis factor-α and apoptosis induction in melanoma cells through histone modification by 3-deazaneplanocin A LINE-1 methylation level and prognosis in pancreas cancer: pyrosequencing technology and literature review.AIM1 is an actin-binding protein that suppresses cell migration and micrometastatic dissemination.

P2860

Q24289344-0371A5B2-A5BB-4264-B6DF-7269B51E8A68 Q26772077-8A4B6B29-258B-48BD-9806-68172BB7D0AF Q26785958-5AFE377E-8A36-4385-88C1-7D18D16175C1 Q27001734-202A1D4E-738C-45AF-871D-89BC69137ACD Q28087759-FDBAF5AF-45BC-4702-A773-1B0189BD3440 Q31159345-4427F3DD-543A-4A03-9B70-77B61F0063E1 Q34019113-A7F4C5D2-C5E6-4A75-8E26-3F8C740065E7 Q34416046-8CA7DBB1-B2D6-4264-B2F7-D357A779DA9C Q34788817-8A095C7C-7868-48C6-87F4-6EBFA3E5D35A Q35237505-888EC1CC-FA91-448C-80D8-57152BB3F6C8 Q36214937-5AFF6F40-D790-41C4-91FB-73A5B738D90E Q36345274-9C60152B-11A1-4FB4-A1D7-A4E062BF4AD1 Q36557527-61D2BE00-D9B9-4160-B316-C8EF27EAD429 Q37349526-6095EAB0-EDE9-47F2-A1E6-540C7FD1B4AA Q37365473-E9D28777-F4F6-47C4-A29C-5C0690409AD0 Q37380194-295E2E61-3F40-4128-AA03-0BF967F5C8E5 Q37667080-C31D5071-51CE-4004-A21B-AB78B4B4604F Q37707015-548AB9A5-0994-4781-A72A-99464A8FF878 Q38152782-D359CF2C-411E-425E-B9A9-52D3C5D5F8DB Q38154781-29BEDB88-B847-4D83-ABB3-EF3AB91FC6DB Q38579541-4640AE85-CAA5-4F85-8EFB-6DFB09EB5329 Q38668171-4BB4ACAE-053F-4C8A-816E-3D27E0C00ACA Q38700529-C8FC6531-ECC5-4B2C-A4B7-162E7EA85C70 Q39063402-D2EFAEB1-8198-4EED-AE52-6E4FC40DAD99 Q39325725-B5041FF4-0C98-4543-9C8A-90E16DB42F57 Q41140861-B38D05B6-9B54-4772-864F-45D45A658FE1

P2860

AIM1 and LINE-1 epigenetic aberrations in tumor and serum relate to melanoma progression and disease outcome

http://www.wikidata.org/entity/Q35962455

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

AIM1 and LINE-1 epigenetic abe ...... rogression and disease outcome

@ast

AIM1 and LINE-1 epigenetic abe ...... rogression and disease outcome

@en

type

label

AIM1 and LINE-1 epigenetic abe ...... rogression and disease outcome

@ast

AIM1 and LINE-1 epigenetic abe ...... rogression and disease outcome

@en

prefLabel

AIM1 and LINE-1 epigenetic abe ...... rogression and disease outcome

@ast

AIM1 and LINE-1 epigenetic abe ...... rogression and disease outcome

@en

P1433

Q35962455-DC31958D-1CAB-4C61-AC32-C0CAEABC9C2C

P1476

Q35962455-4BE2302F-C2BB-4DD6-A6DF-53D8B3A3FCAF

P2093

Q35962455-07D2BA16-AAB3-42CA-A86A-8E1FE68824C9

Q35962455-509A3043-E24E-49B7-B781-17072B3DAF74

Q35962455-5BB0849F-A86F-4084-A03C-34CBE3BCDECF

Q35962455-6A034E5A-03A0-4EE5-9E04-D6DF768F790B

Q35962455-7CD2F88B-CF2E-45AF-B057-4594DBE98996

Q35962455-A6319281-7E65-466E-82DD-4EDE920E7D7B

Q35962455-AEDA8D38-98AC-42E2-BE0A-29AD937331C4

Q35962455-BD3109B8-1B0C-4DEF-90AA-5865B74D53B8

Q35962455-D8A59D58-178F-41CE-AB1F-78E7228AEE32

Q35962455-DFF5C846-387E-429F-81E4-DB75A0CCF0D5

P2860

Q35962455-01CB2FE7-7538-4568-A437-29F3230ADFFD

Q35962455-039FF33A-71BA-4260-977B-97E1252F8044

Q35962455-040EB94B-8DB7-404D-9117-637E22B5A635

Q35962455-0622697D-DB2E-4E61-81E3-5B449E4F75E4

Q35962455-089252AD-01AC-4424-B253-C0F7F6AACC71

Q35962455-163C802B-3BBC-4230-AA12-3E46966239FF

Q35962455-16AD3E27-9A4B-451F-94B2-55DC969957B7

Q35962455-201C7B69-9287-471E-A719-FFD7131C3E3A

Q35962455-2F93582B-9DB4-4984-99D8-7101BE55F08D

Q35962455-358C72F8-8F50-4E3B-8301-BE3276F83D54

P2888

Q35962455-CD88B45B-88C7-4ECF-9205-6562961C8C2E

P304

Q35962455-395B60D7-DC9D-483C-95F5-3AF0C79A9AFC

P31

Q35962455-CF39E621-5398-4EA0-ACD7-C7C9FDF21201

P356

Q35962455-1B9348CF-6AC9-4BBA-83B5-09D420E29A98

P407

Q35962455-D898455A-72D2-4FDD-AC1D-5A17E5423BD9

P433

Q35962455-04DB7A95-50D2-427A-90CF-70F7EB7DF5F7

P478

Q35962455-E163C918-676D-4E8C-AD3E-1A084FEEF63E

P50

Q35962455-034AD814-B916-4A78-A33B-DDA2DB90E336

P577

Q35962455-1D10A428-BBFC-43CA-B047-738B4783B8E2

P5875

Q35962455-4828D6F5-50F3-47F9-9CC8-6C842DE7A413

P698

Q35962455-A7175A7A-3C76-4126-977C-5BCE5276AD61

P932

Q35962455-A44C4A54-E67D-469A-9030-63CB3E9CA8FC

P356

P1433

Journal of Investigative Dermatology

P1476

AIM1 and LINE-1 epigenetic abe ...... rogression and disease outcome

@en

P2093

Christine T Kuo

http://www.w3.org/2001/XMLSchema#string

Dave S B Hoon

http://www.w3.org/2001/XMLSchema#string

Donald L Morton

http://www.w3.org/2001/XMLSchema#string

Kelly K Chong

http://www.w3.org/2001/XMLSchema#string

Michelle W Li

http://www.w3.org/2001/XMLSchema#string

Myung-Shin Sim

http://www.w3.org/2001/XMLSchema#string

Sharon K Huang

http://www.w3.org/2001/XMLSchema#string

Sojun Hoshimoto

http://www.w3.org/2001/XMLSchema#string

Teh-Ling Takeshima

http://www.w3.org/2001/XMLSchema#string

Yoshiki Takei

http://www.w3.org/2001/XMLSchema#string

P2860

Initial sequencing and analysis of the human genome

The DNA sequence and analysis of human chromosome 6

Hot L1s account for the bulk of retrotransposition in the human population

AIM1, a novel non-lens member of the betagamma-crystallin superfamily, is associated with the control of tumorigenicity in human malignant melanoma

Exploring the Limits of Sequence and Structure in a Variant βγ-Crystallin Domain of the Protein Absent in Melanoma-1 (AIM1)

The epigenomics of cancer

Induction of tumors in mice by genomic hypomethylation

Biology of mammalian L1 retrotransposons

The gene expression signatures of melanoma progression

LINE-1 hypomethylation in cancer is highly variable and inversely correlated with microsatellite instability

P2888

P304

1689-1697

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/JID.2012.36

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

132

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-03-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221688417

http://www.w3.org/2001/XMLSchema#string

P698

22402438

http://www.w3.org/2001/XMLSchema#string

P932

3352986

http://www.w3.org/2001/XMLSchema#string